Literature DB >> 11238266

Deceleration time in ischemic cardiomyopathy: relation to echocardiographic and scintigraphic indices of myocardial viability and functional recovery after revascularization.

Y Yong1, S F Nagueh, S Shimoni, K Shan, Z X He, M J Reardon, G V Letsou, J F Howell, M S Verani, M A Quiñones, W A Zoghbi.   

Abstract

BACKGROUND: In patients with heart failure secondary to left ventricular (LV) systolic dysfunction, a short deceleration time (DT) successfully predicts clinical outcome. The impact of myocardial viability and revascularization on the mitral inflow velocities, however, is unknown. METHODS AND
RESULTS: Forty patients with ischemic cardiomyopathy underwent (201)Tl scintigraphy (SPECT) and 2D, Doppler, and dobutamine echocardiography (DE, to 40 microg. kg(-1). min(-1)) 2 days before CABG. Echocardiography was repeated 3 months after revascularization to determine recovery of function. Significant correlations were present between DT and LV contractile reserve by DE (r=0.72), scar perfusion defect by SPECT (r=-0.69), and the change in ejection fraction (DeltaEF) after surgery (r=0.77) (all P:<0.01). DT >150 ms effectively identified (sensitivity 79%, specificity 81%) patients with DeltaEF >/=5%. The population was divided into 2 groups according to DT: group 1 (DT >150 ms, n=21) and group 2 (DT </=150 ms, n=19). At baseline, NYHA class, LV EF, age, and use of cardiovascular drugs were similar between the 2 groups. The number of viable segments by both DE and SPECT, however, was higher in group 1 (both P:<0.01), and only patients in group 1 had an increase in EF (29+/-4.8% to 40+/-8%, P:<0.01) after surgery. Death and heart transplantation occurred in 7 patients from group 2 and 1 patient from group 1 (P:=0.017).
CONCLUSIONS: In patients with ischemic cardiomyopathy, the reduced amount of viable myocardium results in a restrictive mitral inflow pattern, which in turn predicts poor survival.

Entities:  

Mesh:

Year:  2001        PMID: 11238266     DOI: 10.1161/01.cir.103.9.1232

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

Review 1.  Myocardial hibernation in coronary artery disease.

Authors:  Dinesh K Kalra; William A Zoghbi
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

2.  Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial.

Authors:  Maryse Palardy; Lynne W Stevenson; Gudaye Tasissa; Michele A Hamilton; Robert C Bourge; Thomas G Disalvo; Uri Elkayam; James A Hill; Sharon C Reimold
Journal:  Circ Heart Fail       Date:  2009-04-14       Impact factor: 8.790

3.  Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy.

Authors:  Qi Wang; Kang-Yu Chen; Fei Yu; Hao Su; Chun-Sheng An; Yang Hu; Dong-Mei Yang; Jian Xu; Ji Yan
Journal:  Clinics (Sao Paulo)       Date:  2017-07       Impact factor: 2.365

4.  Left atrial geometry and pump function in ischemic cardiomyopathy.

Authors:  Mohammad Abdelghani Abdelzaher; Wael Mohammad Atteia
Journal:  Int J Cardiol Heart Vasc       Date:  2014-10-28

5.  Effect of left ventricular geometric remodeling on restrictive filling pattern and survival in ischemic cardiomyopathy.

Authors:  Srilakshmi M Adhyapak; Tinku Thomas; Ms Tivlin Jose; Kiron Varghese
Journal:  Indian Heart J       Date:  2022-05-02

6.  Incremental prognostic value of echocardiography of left ventricular remodeling and diastolic function in STICH trial.

Authors:  Kyung-Hee Kim; Lilin She; Kerry L Lee; Rafal Dabrowski; Paul A Grayburn; Miroslaw Rajda; David L Prior; Patrice Desvigne-Nickens; William A Zoghbi; Michele Senni; Guglielmo Stefanelli; Cesare Beghi; Thao Huynh; Eric J Velazquez; Jae K Oh; Grace Lin
Journal:  Cardiovasc Ultrasound       Date:  2020-05-28       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.